DarioHealth (NASDAQ:DRIO) Issues Earnings Results

DarioHealth (NASDAQ:DRIO) issued its quarterly earnings results on Thursday. The company reported $8.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.57) by $9.93, FiscalAI reports. DarioHealth had a negative return on equity of 59.47% and a negative net margin of 171.09%.The firm had revenue of $5.23 million for the quarter, compared to analyst estimates of $5.05 million.

DarioHealth Stock Performance

NASDAQ:DRIO opened at $8.93 on Thursday. The company has a current ratio of 4.55, a quick ratio of 4.02 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $60.37 million, a price-to-earnings ratio of -0.80 and a beta of 1.08. The firm’s fifty day simple moving average is $10.86 and its 200 day simple moving average is $11.71. DarioHealth has a twelve month low of $5.93 and a twelve month high of $17.74.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Wall Street Zen cut shares of DarioHealth from a “hold” rating to a “sell” rating in a research report on Sunday, January 25th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, DarioHealth presently has a consensus rating of “Hold” and a consensus target price of $38.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in DRIO. XTX Topco Ltd boosted its holdings in DarioHealth by 229.0% in the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after purchasing an additional 43,513 shares during the last quarter. Geode Capital Management LLC increased its holdings in DarioHealth by 167.9% during the 4th quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after purchasing an additional 31,063 shares during the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in shares of DarioHealth in the 4th quarter valued at approximately $35,000. 33.39% of the stock is owned by hedge funds and other institutional investors.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.